Gyre Therapeutics is a US-based biopharmaceutical company focused on developing and commercializing small-molecule therapies targeting fibrosis and inflammation across multiple organs. Its lead approved product, ETUARY (Pirfenidone), is indicated for idiopathic pulmonary fibrosis and is being evaluated in Phase 3 trials for additional conditions including diabetic kidney disease and interstitial lung disease. The company's broader pipeline includes F351 (Hydronidone), in Phase 3 studies for hepatitis B-related liver fibrosis, and F573, currently in Phase 2 development for acute liver failure.
Frequently asked questions
Is Gyre Therapeutics Inc (GYRE) stock halal to invest in?
Yes. As of , GYRE is Shariah-compliant under AAOIFI standards, so it is considered halal to invest in. Gyre Therapeutics Inc passes both the business screen and the financial screen: its revenue from impermissible activities, its interest-bearing debt and its interest-bearing securities are all within AAOIFI limits, based on its most recent financial reports.
Does Gyre Therapeutics Inc have any interest income?
Yes, Gyre Therapeutics Inc does have interest income. According to the company's latest annual report for
the fiscal year ending Dec 31, 2025, Gyre Therapeutics Inc reported revenue of
$116,588,000 and interest income of
$1,747,000. The interest income represents
1.5% of the combined total. It's worth noting that some companies
may report additional interest income as part of their revenue. For a detailed breakdown of all interest
income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Gyre Therapeutics Inc stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions
(AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes
standards for Islamic finance. Their guidelines help determine if a company's business activities and
financial structure align with Islamic principles. These standards are widely respected in the Islamic
finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and
other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad
Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Gyre Therapeutics Inc stock reviewed for Shariah compliance?
The Shariah compliance status of Gyre Therapeutics Inc stock is reviewed on a regular basis, with a minimum
frequency of once per quarter. However, if there are any significant changes or major developments
in the company's operations that may impact its compliance, an immediate review will be conducted to
ensure ongoing adherence to Shariah principles.
How can I stay updated on Gyre Therapeutics Inc's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within
the Zoya app to receive notifications whenever there is a change in the Shariah compliance of GYRE,
or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate
due to changes in a company's financial ratios or business activities.
Are dividends from Gyre Therapeutics Inc stock considered halal?
Yes, dividends from GYRE are considered halal. However, you may need to purify a portion of the
dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of
revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of
impermissible revenue for Gyre Therapeutics Inc (GYRE), check the Zoya app. For more details on the
purification process, read
our comprehensive guide.
Do I need to pay Zakat on my Gyre Therapeutics Inc shares?
If you hold Gyre Therapeutics Inc stock as an investment, through an Employee Stock Ownership
Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and
meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments
can be complex and depends on various factors. To help make this easy, we've created a free
Zakat calculator for stocks. For a more
seamless experience, use the Zoya mobile app, where you can link your brokerage account to
automatically import holdings.
How to buy Gyre Therapeutics Inc (GYRE) stock on Zoya
Sign up for a free Zoya account It’s easy to get started. You can sign up for an account directly on our website or by downloading the Zoya app for iOS or Android.
Link a brokerage account Zoya partners with leading brokerages like Alpaca and others for a seamless way to buy and manage stocks through Zoya.
Decide how much to invest Navigate to the search screen and type the name of the stock into the search bar. Then, click the buy button and input the amount you'd like to invest, either in terms of dollars or number of shares. Review the real-time stock price and estimated quantity of shares before confirming your investment.
Manage your portfolio in one place You can find your newly purchased stock in your Zoya portfolio alongside the rest of your holdings. Enable alerts to get notified of any changes in your portfolio's Shariah compliance.
Community posts
Related stocks
See how Gyre Therapeutics Inc compares with its peers:
